Bioequivalence of two tacrolimus 1-mg formulations under fasting conditions in healthy subjects: A randomized, two-period crossover trial

Lalitendu Mohanty, Sumit Bhushan, Bernd Rüttger

Open source

DOI
10.5414/cp203534
Published
2020-03-01
Container
Int. Journal of Clinical Pharmacology and Therapeutics
Publisher
Dustri-Verlgag Dr. Karl Feistle
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.5414/cp203534,
  title = {Bioequivalence of two tacrolimus 1-mg formulations under fasting conditions in healthy subjects: A randomized, two-period crossover trial},
  author = {Lalitendu Mohanty and Sumit Bhushan and Bernd Rüttger},
  year = {2020},
  journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
  doi = {10.5414/cp203534},
  url = {https://doi.org/10.5414/cp203534}
}

RIS

TY  - JOUR
TI  - Bioequivalence of two tacrolimus 1-mg formulations under fasting conditions in healthy subjects: A randomized, two-period crossover trial
AU  - Lalitendu Mohanty
AU  - Sumit Bhushan
AU  - Bernd Rüttger
PY  - 2020
JO  - Int. Journal of Clinical Pharmacology and Therapeutics
DO  - 10.5414/cp203534
UR  - https://doi.org/10.5414/cp203534
ER  - 

APA

Mohanty, L., Bhushan, S., & Rüttger, B. (2020). Bioequivalence of two tacrolimus 1-mg formulations under fasting conditions in healthy subjects: A randomized, two-period crossover trial. Int. Journal of Clinical Pharmacology and Therapeutics. https://doi.org/10.5414/cp203534

Source records